Like other alkylating agents,<unk>  is teratogenic and contraindicated in pregnant women (pregnancy category D) except for life-threatening circumstances in the mother. Additional relative contraindications to the use of<unk>  include lactation, active infection, neutropenia or bladder toxicity.<unk>  is a pregnancy category D drug and causes birth defects. First trimester exposure to<unk>  for the treatment of cancer or lupus displays a pattern of anomalies labeled<unk>  embryopathy", including growth restriction, ear and facial abnormalities, absence of digits and hypoplastic limbs.
Cyclophosphamide
Ifosfamide
Vincristine
Lenalidomide
Mitoxantrone
Cytarabine
Cladribine
Phototrexate